Grayanotoxin: Difference between revisions
>Xenny cognitive effects |
>Xenny auditory effects |
||
Line 47: | Line 47: | ||
*'''[[Effect::[[Diarrhea]]]]''' <ref name=":0">Gunduz A, Turedi S, Russell RM, Ayaz FA. Clinical review of grayanotoxin/mad honey poisoning past and present. Clin Toxicol (Phila). 2008 Jun;46(5):437-42. doi: 10.1080/15563650701666306. PMID: 18568799.</ref> - Grayanotoxin-containing plants have been historically used as laxatives. | *'''[[Effect::[[Diarrhea]]]]''' <ref name=":0">Gunduz A, Turedi S, Russell RM, Ayaz FA. Clinical review of grayanotoxin/mad honey poisoning past and present. Clin Toxicol (Phila). 2008 Jun;46(5):437-42. doi: 10.1080/15563650701666306. PMID: 18568799.</ref> - Grayanotoxin-containing plants have been historically used as laxatives. | ||
*'''[[Effect::[[Motor control loss]]]]''' <ref>Ohgaki T, Uchida S, Meguri H, Ogita K, Yoneda Y. Preventive action of quisqualic acid against grayanotoxin-induced suppression of locomotor activity in mice. Neuropharmacology. 1988 Oct;27(10):1045-53. doi: 10.1016/0028-3908(88)90066-4. PMID: 3070432.</ref> | *'''[[Effect::[[Motor control loss]]]]''' <ref>Ohgaki T, Uchida S, Meguri H, Ogita K, Yoneda Y. Preventive action of quisqualic acid against grayanotoxin-induced suppression of locomotor activity in mice. Neuropharmacology. 1988 Oct;27(10):1045-53. doi: 10.1016/0028-3908(88)90066-4. PMID: 3070432.</ref> | ||
*'''[[Effect::[[Temperature regulation suppression]]]]''' - This may manifest as hypothermia. | *'''[[Effect::[[Temperature regulation suppression]]]]''' - This may manifest as [[Temperature regulation suppression|hypothermia]]. | ||
*'''[[Effect::[[Dizziness]]]]''' - This effect may occur along with vertigo <ref name=":0">Gunduz A, Turedi S, Russell RM, Ayaz FA. Clinical review of grayanotoxin/mad honey poisoning past and present. Clin Toxicol (Phila). 2008 Jun;46(5):437-42. doi: 10.1080/15563650701666306. PMID: 18568799.</ref>. | *'''[[Effect::[[Dizziness]]]]''' - This effect may occur along with vertigo <ref name=":0">Gunduz A, Turedi S, Russell RM, Ayaz FA. Clinical review of grayanotoxin/mad honey poisoning past and present. Clin Toxicol (Phila). 2008 Jun;46(5):437-42. doi: 10.1080/15563650701666306. PMID: 18568799.</ref>. | ||
*'''[[Effect::[[Appetite suppression]]]]''' <ref>Jansen SA, Kleerekooper I, Hofman ZL, Kappen IF, Stary-Weinzinger A, van der Heyden MA. Grayanotoxin poisoning: 'mad honey disease' and beyond. Cardiovasc Toxicol. 2012 Sep;12(3):208-15. doi: 10.1007/s12012-012-9162-2. PMID: 22528814; PMCID: PMC3404272.</ref> | *'''[[Effect::[[Appetite suppression]]]]''' <ref>Jansen SA, Kleerekooper I, Hofman ZL, Kappen IF, Stary-Weinzinger A, van der Heyden MA. Grayanotoxin poisoning: 'mad honey disease' and beyond. Cardiovasc Toxicol. 2012 Sep;12(3):208-15. doi: 10.1007/s12012-012-9162-2. PMID: 22528814; PMCID: PMC3404272.</ref> | ||
Line 54: | Line 54: | ||
}} | }} | ||
{{effects/visual| | {{effects/visual| | ||
====Suppressions==== | ====Suppressions==== | ||
Line 65: | Line 62: | ||
====Distortions==== | ====Distortions==== | ||
*'''[[Effect::[[Drifting]]]]''' - This effect is qualitatively similar to that of other cholinergic substances, and is likely a result of the effects of grayanotoxins on sodium channels. | *'''[[Effect::[[Drifting]]]]''' - This effect is qualitatively similar to that of other [[Cholinergics|cholinergic substances]], and is likely a result of the effects of grayanotoxins on sodium channels. | ||
*'''[[Effect::[[Visual haze]]]]''' <ref>Roy, Saurav & Biswas, Soumya & Ghosh, Saikat & Roy, Pragyan. (2019). The Himalayan hallucinogenic honey and its future prospects and proposed uses. 10.13140/RG.2.2.29254.63041.</ref> | *'''[[Effect::[[Visual haze]]]]''' <ref>Roy, Saurav & Biswas, Soumya & Ghosh, Saikat & Roy, Pragyan. (2019). The Himalayan hallucinogenic honey and its future prospects and proposed uses. 10.13140/RG.2.2.29254.63041.</ref> | ||
*'''[[Effect::[[Brightness alteration]]]]''' <ref>Setareh-Shenas S, Kaplin S, Bania TC, Kornberg R. A Rare Case of Mad Honey Disease: A Reversible Cause of Complete Heart Block. JACC Case Rep. 2019 Nov 13;1(4):579-582. doi: 10.1016/j.jaccas.2019.09.015. PMID: 34316883; PMCID: PMC8288791.</ref> - Grayanotoxin may make colors appear darker. | *'''[[Effect::[[Brightness alteration]]]]''' <ref>Setareh-Shenas S, Kaplin S, Bania TC, Kornberg R. A Rare Case of Mad Honey Disease: A Reversible Cause of Complete Heart Block. JACC Case Rep. 2019 Nov 13;1(4):579-582. doi: 10.1016/j.jaccas.2019.09.015. PMID: 34316883; PMCID: PMC8288791.</ref> - Grayanotoxin may make colors appear darker. | ||
Line 72: | Line 69: | ||
====Hallucinatory states==== | ====Hallucinatory states==== | ||
*'''[[Effect::[[External hallucination]]]]''' - Deliriant-like hallucinations have been reported after high-dose ingestion of grayanotoxins, this is rarely reported and is unlikely to occur at common doses. <ref>Shrestha TM, Nepal G, Shing YK, Shrestha L. Cardiovascular, psychiatric, and neurological phenomena seen in mad honey disease: A clinical case report. Clin Case Rep. 2018 Oct 22;6(12):2355-2357. doi: 10.1002/ccr3.1889. PMID: 30564328; PMCID: PMC6293183.</ref> | *'''[[Effect::[[External hallucination]]]]''' - [[Deliriant]]-like hallucinations have been reported after high-dose ingestion of grayanotoxins, this is rarely reported and is unlikely to occur at common doses. <ref>Shrestha TM, Nepal G, Shing YK, Shrestha L. Cardiovascular, psychiatric, and neurological phenomena seen in mad honey disease: A clinical case report. Clin Case Rep. 2018 Oct 22;6(12):2355-2357. doi: 10.1002/ccr3.1889. PMID: 30564328; PMCID: PMC6293183.</ref> | ||
*'''[[Effect::[[Internal hallucination]]]]''' | *'''[[Effect::[[Internal hallucination]]]]''' | ||
Line 82: | Line 79: | ||
*'''[[Effect::[[Confusion]]]]''' | *'''[[Effect::[[Confusion]]]]''' | ||
*'''[[Effect::[[Irritability]]]]''' <ref>Ullah S, Khan SU, Saleh TA, Fahad S. Mad honey: uses, intoxicating/poisoning effects, diagnosis, and treatment. RSC Adv. 2018 May 22;8(33):18635-18646. doi: 10.1039/c8ra01924j. PMID: 35541133; PMCID: PMC9080652.</ref> | *'''[[Effect::[[Irritability]]]]''' <ref>Ullah S, Khan SU, Saleh TA, Fahad S. Mad honey: uses, intoxicating/poisoning effects, diagnosis, and treatment. RSC Adv. 2018 May 22;8(33):18635-18646. doi: 10.1039/c8ra01924j. PMID: 35541133; PMCID: PMC9080652.</ref> | ||
*'''[[Effect::[[Sleepiness]]]]''' - At sufficient doses, grayanotoxins may cause sedation and even a sudden loss of consciousness <ref>Jansen SA, Kleerekooper I, Hofman ZL, Kappen IF, Stary-Weinzinger A, van der Heyden MA. Grayanotoxin poisoning: 'mad honey disease' and beyond. Cardiovasc Toxicol. 2012 Sep;12(3):208-15. doi: 10.1007/s12012-012-9162-2. PMID: 22528814; PMCID: PMC3404272.</ref>. | *'''[[Effect::[[Sleepiness]]]]''' - At sufficient doses, grayanotoxins may cause [[sedation]] and even a sudden loss of consciousness <ref>Jansen SA, Kleerekooper I, Hofman ZL, Kappen IF, Stary-Weinzinger A, van der Heyden MA. Grayanotoxin poisoning: 'mad honey disease' and beyond. Cardiovasc Toxicol. 2012 Sep;12(3):208-15. doi: 10.1007/s12012-012-9162-2. PMID: 22528814; PMCID: PMC3404272.</ref>. | ||
*'''[[Effect::[[Cognitive euphoria]]]]''' - This effect manifests as a sense of relaxation <ref>Shrestha TM, Nepal G, Shing YK, Shrestha L. Cardiovascular, psychiatric, and neurological phenomena seen in mad honey disease: A clinical case report. Clin Case Rep. 2018 Oct 22;6(12):2355-2357. doi: 10.1002/ccr3.1889. PMID: 30564328; PMCID: PMC6293183.</ref> | *'''[[Effect::[[Cognitive euphoria]]]]''' - This effect manifests as a sense of relaxation <ref>Shrestha TM, Nepal G, Shing YK, Shrestha L. Cardiovascular, psychiatric, and neurological phenomena seen in mad honey disease: A clinical case report. Clin Case Rep. 2018 Oct 22;6(12):2355-2357. doi: 10.1002/ccr3.1889. PMID: 30564328; PMCID: PMC6293183.</ref> | ||
*'''[[Effect::[[Cognitive dysphoria]]]]''' <ref>Ullah S, Khan SU, Saleh TA, Fahad S. Mad honey: uses, intoxicating/poisoning effects, diagnosis, and treatment. RSC Adv. 2018 May 22;8(33):18635-18646. doi: 10.1039/c8ra01924j. PMID: 35541133; PMCID: PMC9080652.</ref> | *'''[[Effect::[[Cognitive dysphoria]]]]''' <ref>Ullah S, Khan SU, Saleh TA, Fahad S. Mad honey: uses, intoxicating/poisoning effects, diagnosis, and treatment. RSC Adv. 2018 May 22;8(33):18635-18646. doi: 10.1039/c8ra01924j. PMID: 35541133; PMCID: PMC9080652.</ref> | ||
Line 89: | Line 86: | ||
}} | }} | ||
{{effects/auditory| | {{effects/auditory| | ||
*'''[[Effect::[[Auditory acuity suppression]]]]''' <ref>Demircan A, Keles A, Bildik F, Aygelcel G, Dogan NO, Gomez HF. Mad honey sex: Therapeutic misadventures from an ancient biological weapon. An Emerg Med 2009; 54: 824-9</ref> | |||
}} | }} | ||
Line 113: | Line 107: | ||
{{DangerousInteractions}} | {{DangerousInteractions}} | ||
{{DangerousInteractions/Intro}} | {{DangerousInteractions/Intro}} | ||
*'''[[Cholinergics]]''' - Because grayanotoxins potentiate the effects of [[acetylcholine]], | |||
==Legal status== | ==Legal status== | ||
{{LegalStub}} | {{LegalStub}} |